Details
Description
In this report we described baseline characteristics and the duration of follow-up time among new users of 24 new molecular entities (NMEs) approved in 2008 and 25 NMEs approved in 2009 by the U.S. Food and Drug Administration in the Sentinel Distributed Database (SDD).